Tilt Biotherapeutics raised €22M in a funding round in Feb 2023. The company is based in Helsinki, Finland. Investors in the round: Lifeline Ventures. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €22M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
